Home/Filings/4/0001415889-24-000817
4//SEC Filing

Brockstedt Dirk G. 4

Accession 0001415889-24-000817

CIK 0001673772other

Filed

Jan 7, 7:00 PM ET

Accepted

Jan 8, 5:50 PM ET

Size

5.1 KB

Accession

0001415889-24-000817

Insider Transaction Report

Form 4
Period: 2024-01-05
Brockstedt Dirk G.
CHIEF SCIENTIFIC OFFICER
Transactions
  • Sale

    Common Stock

    2024-01-05$22.78/sh898$20,45627,820 total
Footnotes (2)
  • [F1]These shares were sold solely to pay taxes due upon vesting of the Restricted Stock Units granted on January 30, 2020 for 8,000 shares.
  • [F2]Includes 1,646 shares and two shares acquired by Reporting Person under the Issuer's 2019 Employee Stock Purchase Plan on April 28, 2023 and October 31, 2023, respectively.

Issuer

RAPT Therapeutics, Inc.

CIK 0001673772

Entity typeother

Related Parties

1
  • filerCIK 0001635616

Filing Metadata

Form type
4
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 5:50 PM ET
Size
5.1 KB